Vascular Patches Market Size

Vascular Patches Market Analysis

During the time frame of the forecast, the vascular patch market is expected to grow at a CAGR of 7.4%.

COVID-19 impacted the growth of the vascular patch market owing to the decreased number of vascular surgeries due to the restrictions imposed by the government to avoid the spread of coronavirus. For instance, according to an article published in Frontiers in Surgery, in August 2022, there was a 34.51% decrease in the surgical procedures reported in central Romania during a pandemic, with a disproportionate 80.6% decrease in the number of cases admitted with a diagnosis of venous insufficiency and an increase of 67.21% in the number of patients admitted with acute arterial ischemia. Also, as per the data published by the Society of Thoracic Surgeons, in April 2021, about a 52.7% reduction in adult cardiac surgery volume and a 65.5% reduction in elective cases were reported in the United States. This has impacted the demand for vascular patches during the pandemic period. However, the resumed vascular surgical procedures and the high risk of developing atherosclerosis in COVID-19 patients have increased the number of surgeries performed. For instance, as per a research study published in PLOS One in April 2021, COVID-19 could increase the development of atherosclerosis due to ACE2, which is also a receptor for the Sars-CoV-2 virus. Hence, increasing COVID-19 could increase the development of atherosclerosis, which would fuel the demand for surgery. This is anticipated to increase the demand for vascular patches, which in turn is anticipated to fuel market growth in the post-pandemic era.

Over the next few years, the market is expected to grow because of things like the growing number of older people, the rise in vascular diseases, and the growing use of biological patches.

The market is also growing because people are living longer, which makes them more likely to get vascular diseases.For instance, according to an article published in the Cell Journal in May 2022, it has been observed that atherosclerosis is primarily a disease of the elderly, and most myocardial infarctions and strokes occur in the population aged 55 years or older. Also, as per an article published in Arteriosclerosis, Thrombosis, and Vascular Biology in May 2021, it has been observed that the prevalence of peripheral artery disease (PAD) is higher in women than in men. In addition, men aged 85 years or older have a higher prevalence of PAD as compared to men aged 55 to 59 years. Thus, the high burden of atherosclerosis and PAD among the aging population requires cardiac surgeries. This is likely to make more people want to use vascular patches, which will help the market grow.

Additionally, the growing burden of vascular diseases among the population is expected to increase the demand for surgeries and effective treatment, which is also contributing to market growth. According to WHO data, an estimated 1.28 billion adults worldwide aged 30-79 years had hypertension in August 2021, with the majority (two-thirds) living in low- and middle-income countries, and 46% unaware that they had the condition.Thus, a large number of people living with hypertension are at high risk of developing myocardial infarction, stroke, and peripheral vascular disease due to functional changes in blood vessels and the myocardium (left ventricular hypertrophy). This is likely to boost market growth.

The increasing number of research and development activities in the manufacturing of vascular patches is also significantly improving the growth of the market. For instance, as per an article published in the Materials Today Bio Journal in April 2022, the innovative hybrid 3D printing biotechnology has the potential for broad application in regenerative medicine and potentially in heart disease prevention. Researchers think that these kinds of studies will speed up the development of more advanced vascular patches, which will help the market grow.

Furthermore, rising company activities in developing effective vascular patches and increasing product launches are also expected to fuel market growth. For example, Terumo Corporation started a global surgical graft study called PANTHER in September 2021. This was a prospective and retrospective study of a wide range of knitted and woven surgical grafts and cardiovascular patches.

Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. But the risk of an immune response and serious complications, as well as product failures and recalls, are likely to slow the growth of the vascular patch market over the next few years.